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Propositions about an abnormal fatty acid metabolism in 
atopic dermatitis patients prompted us to compare the phos-
pholipid fatty acid composition and L TB4 release of neutro-
phils from 15 atopic dermatitis patients, as well as the adipose 
tissue triglyceride fatty acid composition, to that of 15 
healthy contro ls matched by age, gender, and smoking ha-
bits. We found no differences in the tissue fatty acid compo-
sition between the two groups. The release of leukotriene B4 
T he relationship between dietary. fatty acids and infl am-matory skin disease has been revtewed by Burton [1] . He advocated the use of dietary n-3 and n-6 fatty acid supplements in atopic dermatitis (AD). In a recent meta-analysis of nine doubl e-blind supplementation 
trials with evening primrose oi l in AD patients, Morse, Horrobin, 
Manku et al [2] concl uded that the intake of this o il was associated 
with highly significant improvements in the condition of the pa-
tients, particularly in itch. The rationale behind using evening 
primrose oil was its hi gh content of gamma-linolenic acid, th e 
delta-6-desaturation product of linoleic acid. These authors had 
prev iously proposed [3] that the biochemical cause of atopy was a 
defective functioning of the enzyme delta-6-desatu rase. Inhibition 
of fatty acid desaturation is assumed to lead to an imbalance in th e 
synthesis of fatty acid metabolites like prostaglandins and leuko-
trienes [4] , which are important medi ators of inflammation [5] . 
Dihomogamma-linolenic acid, the elongation product of gamma-
linolenic acid , is a precursor of prostaglandin E 1 and 15-hydroxy-ei-
cosatrienoic acid , both substances with putative anti-inflammatory 
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Abbrev iations: 
AD: atopic dermatitis 
FAME: fa tty acid methyl es ter 
HPLC: hi gh-pressure liqu id chromatography 
LTB4 : lcukotriene B4 
MUFA: monounsaturated fatty acids 
n-3: n-3 fatty acids 
n-6: n-6 fatty acids 
PGE2 : prostaglandin E2 
PMN: polymorphonuclear granulocytes, neutrophils 
P /S-ratio: polyunsaturated to saturated fatty acid ratio 
PUFA: polyunsaturated fatty acids 
from Ca-ionophore- stimulated neutrophils in patients was· 
on the average only 42% (p < 0.001) of that measured in the 
control group, despite the very simil ar arachidonic acid con-
tents of these cells. Our study does not support the assump-
tion of an abnormal fatty acid desaturation in atopic dermati-
tis patients. Rather, the capacity to release and/or convert 
arachidonic acid into leukotrienes in neutrophils appears to 
be affected by this disease. J Invest Derma to! 96: 16 - 19, 1991 
properties [6], w hereas arac hidonic acid is th e precursor of pro-in-
fl ammatory substances like leukotriene B 4 (L TB4 ) and pi·ostag lan-
din E2 (PGE2 ) [5] . Several workers have indeed found elevated le-
vels ofL TB4 and PGE2 in lesiona l atopic skin [7 ,8] and an altered in 
vitro release of eicosanoids from leukocytes in atopic pat ients [9]. 
In order to test the assumption of red uced ac ti vity of the enzyme 
delta-6-desaturase, it is necessary to match the patients to healthy 
controls with regard to age and gender, because small differences 
accord ing to these parameters have been observed in the tissue fatty 
acid composition [10]. Another important determinator is th e diet 
[11]. Leukocytes have been s(t ggested to be use ful ce ll s in which to 
study essential fatty acid metabolism [12]. They display delta-6-de-
saturase activity [1 2] and produce infl ammatory fatty acid m etabo-
lites, such as leukotrien es [13] . W e chose th e polymorphonuclear 
neutrophil (PMN) to study the phospholipid fa tty acid composi-
tion, as a measure of fatty acid metabolism, because this cell type is 
the most abundant leukocyte in th e blood and prominent at sites of 
infl ammation [14]. In order to eva luate th e importance of PMN 
fatty acid composition for leukotriene sy nthesis, we also measured 
the in vitro production of L TB4 in th ese cells. W e compared 15 AD 
patients with 15 hea lthy control s, matched by gender, age, and 
smoking habits. Furthermore, we compared the dietary intake oi 
the two groups. Finally, we measured th e subcutaneous adipose 
ti ssue tri glyceride fatty acid co mpositio n, which is co nsidered to 
be a good measure of the fatty acid co mposition of th e habitual 
diet[ll]. · 
MATERIALS AND METHODS 
Subjects Fiftee n ~dult patients with AD, eight premenopausal 
women and seven men, attending the Department of Dermatol ogy, 
Marselisborg Hospital, agreed to participate in th e study. The age 
range was from 19 to 51, th e mea n age was 32 ± 10 years. In 11 of 
the patients, ecze ma had commenced before th e second year of li fe . 
In one patient, it started at age 15 , and in three during adulthood, 
Five were smokers. None of th e patients received topical or systemir 
trea tment 2 weeks prior to th e study. The affected body s urfac~ 
ranged from 3o/o to 70o/o. In 10 of th e patients, it ranged from 10 to 
SOo/o. Four of the female patients used oral contraceptives. ExclusiOI\ 
criteria were over- or und erweight differing by more than 20% 
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fro m idea l weight, diabetes, and hyperlipidemia. A group of hea lthy 
volunteers was matched co th e patients with regard to age, ge nder, 
and smoking habits. All had a negati ve perso nal and fami ly history 
of ato py. Three of th ese women used o ral co ntraceptives. Patients 
and con trol s had sim il ar lifes ty les. Fasting blood sa mpl es and subcu-
taneous ad ipose tissue biopsies were obtained from all participants. 
The habitual dietary intake of each part icipant was es timated by a 
tra ined nutritioni st, using th e di etary history interview as described 
previous ly (15] . The stud y was approved by th e Ethica l Committee 
o n Human Studtcs m th e county o f Aarhus. 
Sampling Blood sa mples (1 20 ml) were co ll ected after over-
night fasting by venipuncture into 25-ml blood tubes containing 
0.25 ml heparin (5000 IE/ml). Plasma was immediately recovered 
and froze n at- 20oC. Erythrocytes were precipitated with dextran, 
and PMN isolated from th e residual blood by th e H ypaque-Fico ll 
technique as described by Boyum [1 6]. This method yields cell s of 
g reate r than 97% purity, as determined by morpho logy. Viability 
was greater than 97%, as exa min ed by trypan blue exclusion. The 
PMN were suspended in phosphate-buffered sa line, pH 7.0, at a 
co nce ntratio n of approximate ly 6 X 107 cel ls/mi. Adipose tissue 
biopsies were taken from the buttock with th e use of a Luer-lock 
sys tem co nsistin g of a need le, an adaptor, and an evacuated blood 
tube, as described previous ly [1 7]. 
Lipid Extraction and Analysis All solvents were of hi gh-pres-
sure liquid chromatography (HPLC) grade (Rathburn, Pebbleshire, 
UK). Th e PMN (approx imate ly 5 X 107 cells) were pelleted at 
1000 X g fo r 10 min and th e sa line discarded. Lipids were extracted 
accordin g to Folch , Lees , and Stanley [18], with 5 ml chloroform/ 
methanol (2: 1 v /v) co ntaining 50 mg/1 buty lated hydroxy toluene 
(BHT) as an antioxidant. The extract was washed with 1.25 ml 
0.88% KC l and phases separated by centrifu gation . The lower or-
ga ni c phase was aspirated and divide~ into two parts and dried at 
40 oC in a stream of mtrogcn. Th e ltptd was taken up 111 100 J.L I 
chl oroform . Phospholipids were iso lated by so lid-phase extraction 
on disposable silica co lumns (1 ml, Bond Elut, Mikrolab, Aarhus, 
Denmark). After appli cation of th e sa mp le, neutral lipids were 
eluted wit h 5 ml chl oroform and discard ed . Phosphol ipids were 
e luted w ith 8 ml methanol. Purity of th e fract ions was exa mined by 
thin -l aye r chromatograph y on sili ca G gel (Merck, Darmstadt , 
West German y) with the so lvent system heptane/di eth yl eth er/ 
acet ic ac id 70: 20 : 4 (v /v /v). Ex traction of ad ipose tissue trigl ycer-
ides was perform ed as described prev iously [17J, with diethyl eth er. 
The phospholipid ex tract of PMN and th e ad ipose tissue ex tract 
were taken to dryness under nit rogen at 40 •c . Fatty acid methyl 
esters (FAME) were prepared by transesterification with sodium 
methoxide [1 9]. For gas chro matog raph y (GC) , FAME were dis-
so lved in isooctane to a concentration of about 500 J.Lg/ml. 
Gas Chr01natography The gas chro matograph used was model 
437 A (C hrompack, Delft, The N eth erl ands) equipped with an auto-
m atic on-column sa mpl er (Model 912, C hrompack). FAME 
(0.4 til) were injected o nto a no n-coa ted glass preco lumn (0.5 m X 
0.32 mm) befo re bein g sepa rated on a 50 m X 0. 25 mm capillary 
g lass co lumn coated with a 0.2-,um fi lm of P SIL88 (C hrompack). 
H elium was used as the carri er gas at a Aow rate of 2 ml / min . 
Inj ecti on was on-co lumn at 9o •c. The oven was programmed to 
r ise to 210 oC within 6 min and th en run isotherma ll y for 18 min. 
Integ ratio n was performed on a Shimadzu mod el -3RA.. FAME 
were identifi ed by mea ns of a standard mi xture of known co mposi-
tion (Nu-Chcck, Elysian, MN). The coe ffi cient of variation for 
linoleic acid in duplica te samples in PMN and adipose tissue was 5% 
and 1%, respecti ve ly. 
LTB• Synthesis in PMN Purifi ed PMN were suspended at a 
concentratio n of 2 X 107 ce ll s/ml in phosphate-buffered sa line 
conta in ing 0.87 mM CaC12 , pH 7.0, and incubated in duplicate for 
5 min at 3rC with 5 JLM A23187 (Ca lbioc hem, La j o ll a, CA). The 
react io n was termin ated by additio n o f 2 ml icc-co ld methanol. 
Lipids we re ex tracted and reverse-phase HPLC carried out as de-
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Table I. Body Mass Index and Intake of Major Nutrients• 
Body mass index (kgjm 2) 
Energy intake (MJ) 
Protein intake (% energy)1 
Carbo hyd rate intake (% energy)1 
Fat intake (% energy)1 
Saturated fat (% )' 
Linoleic acid (%)' 
.. Values arc mean ± SO. 
b o/o of total energy . 
Controls 
23.5 ± 4.7 
10.0 ± 1.9 
14.5 ± 2.7 
39.8 ± 5.9 
40.9 ± 4.4 
40. 3 ± 4.8 
11.0 ± 2.8 
' Significantl y different from controls {p < 0.05}. 
J o/o by weight of total fat. 
Patients 
22.9 ± 4.5 
10.4 ± 2.8 
14.4 ± 2.4 
45 .1 ± 6.7' 
36.8 ± 6.3 
36.2 ± 5.7 
14.7 ± 6.9 
scribed previously (20]. UV absorption was monitored at 270 nm. 
LTB4 was quantitated by use of an external standard so lution of 
L TB4 (Merck-Frosst, Quebec, Ca nada). 
Statistical Analysis All data are presented as mean ±SO. Com-
parisons between patients and controls were rnade by Student t test 
for non-paired data. All p va lues are two tailed. Regression and 
correlation anal yses were performed with the statistica l package 
"Statgraphics" (version 2.6, Statistical Graphics Corporation, 
Rockville , MD). 
RESULTS 
The body-mass index and the dietary intake of major nutrients of 
th e participants is given in Table I. The dietary intake of patients 
and contro ls differed significantly (p < 0.05) only with regard to 
carboh ydrates. On average, controls consumed slightly (non-signifi-
ca ntl y) more saturated fat and less linoleic acid compared to the 
patients. 
T he fatty acid composition of PMN phospholipids is given in 
T able II . No significant differences were found between patients 
and controls except for palmitic acid, which was 9% higher in 
patients . Significant correlations were found between the major 
fatty ac id groups, SFA, MUFA, and PUFA. The correl ation coeffi-
cients were significant (p < 0.05) for patients and controls taken 
separately, and were scattered around th e same regression lines . 
Strong negative correlations were observed between MUFA and 
PUFA (r,11 = - 0.65 p < 0.001) and SFA and PUFA (r,11 = - 0 .56 
p < 0.01 ). No significant co rrelation was found between the dietary 
intake of linoleic acid and PMN linoleic acid in either patients or 
controls. 
The relative content of PUFA in ad ipose tissue triglycerides is 
given in Table III. On average, patients had sli ghtly higher levels of 
linoleic acid in th eir adipose tissue triglycerides, corresponding to a 
sli ghtly hi gher dietary intake, but no statistica lly significant differ-
ences were found. 
The average LTB4 production by Ca-ionophore (A23187)-stimu-
lated PMN was 28.7 ± 12.5 ng/106 cel ls in th e patients and 
67.6 ± 28.4 ng/106 cell s in co ntrols. This difference was statisti-
ca lly significant (p < 0 .001 ). However, the leve l of the precursor, 
arachidonic acid, in PMN phospholipids was similar in th e two 
groups (Fig 1). The LTB4 production in PMN did not correlate 
with the amount of arachidon ic acid in the PMN phospholipids in 
either patients or controls. The LTB4 production was also not found 
to be related to the severity of disease in the patients. 
DISC USSION 
Fatty acid desaturation is_ subject to_ bo~h hormonal and dietary influ-
ences. ln sulm and a ht gh protem mtake activate this reaction 
whereas fa stin g and glucago n suppress it [21]. Therefore, whet~ 
groups are to b_e compared with regard to the tissue fatty acid com-
position , as an mdtrect measure of fatty acid desa turation , it must be 
asce rtained that th eir dietary intake is not exceedingly different. 
The on ly stgmfi cant dtfference between patients and contro ls in our 
study was in th eir carbohydrate intake. 
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Table II. Fatty Acid Composition of Neutrophil Phospholipids• 
Controls Patients 
Farcy Acid 11 = 15 n = 15 
16:0 11.08 ± 0.80 12. 16 ± 1.49b 
16: 1' 1.35 ± 0.35 1.38 ± 0.39 
17:0 0.27 ± 0.03 0.30 ± 0.07 
17: 1' 0.09 ± 0.07 0.12 ± 0.04 
18:0 17.24 ± 1.41 16.06 ± 2.07 
18 : 1' 30.83 ± 1.35 30. 16 ±1.82 
18:2 n-6' 11.86 ± 1.06 12.15 ± 1.21 
20:0 0.25 ± 0.04 0.25 ± 0.10 
18:3 n-6 0.05 ± 0.05 0.08 ± 0.02 
20:1 n-11 1.14 ± 0.12 1.10 ±0.15 
18:3n-3 0.12±0.03 0.10 ± 0.04 
20: 1 n-9 0.26 ± 0.10 0.24 ± 0.09 
20:2 n-6 0.73 ± 0.08 0.77 ± 0.15 
22:0 0.14 ± 0.06 0.13 ± 0.07 
20:3 n-6 1.95 ± 0.36 2.22 ± 0.70 
22 :1 n-9 0.17±0.10 0.23 ± 0.10 
20:4 n-6 16.35 ± 1.61 15.93 ± 2.26 
20:5 n-3 0.79 ± 0.38 0.63 ± 0.29 
22:4 n-6 1.77 ± 0.31 2. 10 ± 0.58 
22:5 n-6 trace trace 
22 :5 n-3 1.63 ± 0.44 1.78 ± 0.52 
22:6 n-3 1.74 ± 0.55 1.85 ± 0.54 
Sf Ad 29.0 ± 1.5 28.9 ± 1.8 
MUFA< 33.9 ± 1.5 33.3 ± 2.0 
PUFN 37.1 ± 2.0 37.8±2.1 
Total n-6x 32.8 ± 1.9 33.4 ± 2.0 
Total n-31• 4.3 ± 1.3 4.4 ± 1.1 
P/S ratio' 1.3 ± 0.1 1.3 ± 0.1 
• Values arc mean± SD and expressed as% by weight of total fatty acids. 
' Significantly different from controls, p < 0.05. 
{ Including various isomers. 
' Saturated fatty acids. 
~Monounsaturated fatty acids. 
J Polyunsaturated fatty acids . 
x 11-6 fatty acids. 
'' n-3 fatty acids. 
'Polyunsaturated/ saturated fatty acid ratio. 
The fatty acid composition of PMN phospholipids has on ly been 
analyzed in a few studies, and to our knowledge, it has never bee_n , 
done w ith capillary gas chromatography. Our fatty aCid data cit-
verge sl ightly from those of Rocklin, Th istl e, Gallant et al (22]. The 
level of arachido nic acid was 6% hi gher in our data and that of 
palmitic acid 6% lower. The level of 18:3 n-3 found by these 
authors was 1.3% of total fatty acids, w hereas in our study it was 
around 0.1 %. These differences could be due to the fact that 18:3 
n-3 and 20: 1 n-11 often do not separate on packed GC columns. 
The twofold hi gher level of long-chain n-3 fatty acids in the PMN 
in our study group cou ld be due to a hi gher intake of fish in the 
Danish compared to the American diet. The difference Ill the rela-
tive content of arachido nic acid in PMN phospholipids between 
atopic patients and contro ls, reported by Rocklin et al [22], was 
wrongly considered to be significant. * Thus, th eir results for atopic 
patients with all ergic rhinitis and/or asthma correspond with ours 
for AD patients, namely, that there arc no significant differences 
between patients ;md contro ls in th e relative content of PUFA in 
PMN phospholipids. The fact that we fo und the sa me type and 
strength of associations among fatty acids in both patients and con-
trols further indicates that there are no abnormalities in fatty acid 
desaturation in PMN of AD patients. Because no differences were 
found in adipose tissue tri glycerides either , our data do not support 
* D. l-lorrobin (personal communication). 
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Table III. n-6 and n-3 Fatty Acids in Adipose Tissue 
Triglycerides• 
Controls Patients 
Fatty Acid 11 = 15 11 = 15 
18:2 n-6 12.16 ± 1.87 12.65 ± 2.46 
18:3 n-6 0.32 ± 0.10 0.37 ± 0.10 
20 :3 n-6 0.23 ± 0.03 0.24 ± 0.04 
20:4 n-6 0.36 ± 0.10 0.33 ± 0.10 
22:4 n-6 0.10 ± 0.03 0.09 ± 0.04 
Total n-6b 13.43 ± 1.98 13.94 ± 2.40 
18:3 n-3 0.90 ± 0.18 0.91 ± 0.14 
20:5 n-3 0.06 ± 0.03 0.04 ± 0.02 
22 : 5 n-3 0.21 ± 0.07 0.19 ± 0.07 
22:6 n-3 0.02 ± 0.09 0.17 ± 0.08 
Total n-3'• 1.51 ± 0.34 1.43 ± 0.26 
P /S ratio' 0.56 ± 0.13 0.58 ± 0.14 
n-3 / n-6 ratio 1.1 3 ± 0.20 1.05 ± 0.23 
'Values arc mean± SD and expressed as% by we ight of total fatty acids. 
b Jncludi11g other n-6 (n-3) fatty acids than given in this table. 
'Polyunsaturated/saturated fatty acid ratio. 
the hypothesis put forward by Manku et al (3), of a defective func-
tioni ng of the enzyme delta-6-desaturase in AD ·patients. Further-
more, their findin gs of an elevated level ofl inoleic acid and reduced 
levels of metabolites beyond the dclta-6-desaturatio n step in plasma 
phospholipids (23} have not been confirn<ed by other investigators 
[24,25}. 
The usc of the plasma phospholipid fatty acid composition as 
an indicator of fatty acid metabo li sm can be guestioned, because 
plasma lipids show hi gh correlations with dietary fat and respond to 
dietary changes within a few days (26]. A high intake of linoleic acid 
(5 -10% energy) in humans has been shown to result in an elevation 
of linoleic acid and a decrease of arachidonic acid in plasma [27]. 
Thus, dietary habits could fully exp lain the particular fatty acid 
pattern of plasma phospholipids seen in some groups of AD patients. 
Another thing to consider regarding fa try acid desaturation is that it 
can be inhibited by gl ucoco rticoids (21]. Topical glucocorticoids, 
whtch can be absorbed systematicall y, are often used in the treat-
ment of AD. Our patients had not received such treatment for at 
least 2 weeks prior to the study. 
The observed red uced release of LTB4 by stimulated PMN of 
atopic patients, in response to non-specific stimulation w ith Ca-
ionophore A23187, was not due to low levels of its precursor arachi-
do_nic acid in PMN phospholipids, as was the case in essential fatty 
actd-defi cJent rats and monkeys [28,29]. Thus, leukotriene release 
from Ca-ionophore-stimulated cell s is not solel y determined by 
the total arachidonic acid co ntent. T he reduced release of LTB~ 
could be a sign of a disturbed cellular regulation at the level of either 
arachidonic acid release or lipoxygenase activity. Alternatively, the 
arachidonic acid distribution among different phospholipid classe~ 
could have been skewed in patients. C hilton [30) has reported that 
speci~c pl~ospl:olipid s , like ~-ether-linked phosphol ipids, supply 
arach1domc aCid for leukotnene synthesis and that only a small 
portion of the released arachidonic acid actually forms leukotrienes, 
Our method could th erefore be too crude to detect small displace, 
ments in th e distribution of arachidonic acid among phospholipiq 
subclasses. Ruzicka and Ring [11) found a sli ghtly reduced release of 
L TB4 in Ca-ionopbore - stimulated mixed leukocytes in atopic pa, 
tients. However, when employing physiologic stimuli , like anti, 
IgE and complement factor Sa, an increased release ofPGE2 , L TC4 , 
and LTB4 was observed. These findings suggest that the non-spe, 
ctfic and non-physiologic stimulation with Ca-ionophore does not 
imitate the in vivo situatio n, but rather expresses the capacity of ~ 
given cell to sy nthesize leukotrienes. This capacity was neverth el es~ 
reduced in our group of AD patients. 
Our study group was sma ll and not randoml y selected, whicl\ 
leaves one uncertain as to what degree th ese resu lts can be ge neral, 
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Figure 1. LTB4 release and phospholipid arachidonic acid content of neu-
trophil s. LTB4 release was induced by the Ca-ionophore A23187. 
ized. However, the results do not favo r the idea that the reported 
beneficial effects of supplementation with evening primrose oil [2], 
containing gamma-linolenic acid, in AD pati~nts shou~d depend o.n 
bypassing the delta-6-desaturatton step. It ts n~w ttme fo~ tlus 
th eory to be either substantiated by hard data, or dtsmtssed entirely. 
The tecl11tica l assista11ce of Berit Kristwsw is gratefully acknowledged. 
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